CLINICAL_TRIALS
other
· 2026-04-21
Clinical Trial Update: ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer [Phase 3]
Summary
A Phase 3 clinical trial update announcing recruitment for pumitamig in patients with triple-negative breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioNTech SE | Conditions: Breast Neoplasms | Phase 3 | Status: RECRUITING